School of Pharmacy Faculty Member Appointed to Board of the Cochrane Heart, Stroke and Circulation Thematic Group
Hernandez brings to the board expertise in systematic review methodology, cardiovascular diseases, collaborative work with researchers from South America and prior work within Cochrane. He is an expert in systematic reviews and meta-analyses and has been working for several years in the former Cochrane Heart Group as author, peer reviewer and editor. He performs collaborative work with researchers from several countries and languages, especially Peru and Brazil.

Cardiovascular disease is one of the 12 broad topic areas of importance identified by Cochrane and the World Health Organization (WHO). Cochrane has brought together the four former Cochrane groups – Cochrane Heart, Cochrane Hypertension, Cochrane Stroke, and Cochrane Vascular – into a single Thematic Group. This group is led by Professor Gillian Mead of the University of Edinburgh, UK. It shares collective expertise and knowledge and ensures that evidence synthesis in cardiovascular disease reflects the multimorbidity paradigm, the large global burden of vascular disease (including in developing countries), and the continuous development of interventions and diagnostic tests for these conditions.
Professor Hernandez’s work on the board will help map existing reviews and identify areas of overlap of interventions and cardiovascular diseases, identify high priority reviews and updates, provide topic, content and editorial expertise to the Cochrane central team, and create a dissemination strategy of updated and new reviews within the Group.
C. Michael White, Pharm.D., FCP, FCCP, FASHP, Distinguished Professor and Chair of Pharmacy Practice, noted, “Cochrane is the major international body behind systematic reviews and it is wonderful that they recognized the expertise that Dr. Hernandez brings. From his stellar publication record and international presentations on cardiovascular diseases, to his high-quality reviewing for cardiovascular journals across the globe, I am sure he will provide tremendous value to the organization.”
Latest UConn Today
- UConn John Dempsey Hospital Nationally Recognized for Excellence in Stroke and Heart Attack CareUConn John Dempsey Hospital has once again been nationally recognized for delivering high-quality, lifesaving care—earning three major 2025 awards from the American Heart Association.
- UConn’s Journalism Major Offers Pathways to Legal CareersThrough courses like Media Law and Investigative Reporting, journalism students get early exposure to the legal world — inspiring some alumni to pursue law school and careers in public service.
- For Restoring Biodiversity Look for Help from the Humble, World-building Muskrat'These important aquatic rodents transform habitats in many ways that some communities, like the Native Americans, have appreciated for 1000s of years, and Western science is just now discovering that importance'
- World-First Gene Editing Trial for Rare Genetic Disease at UConn HealthUConn Health and Connecticut Children’s have made history by dosing the first patient in a clinical trial using gene editing to treat glycogen storage disease type 1a (GSD1a)
- Professor Sir Cato T. Laurencin of UConn Honored by the American Institute for Medical and Biological EngineeringSir Cato T. Laurencin, M.D., Ph.D., K.C.S.L, was the designated honored guest at the American Institute for Medical and Biological Engineering (AIMBE) President's Circle Reception in Washington, DC.
- School of Nursing Class of 2029 Student Profiles: Abigail Griffiths and Katherine WojtasMeet two out-of-state students who share a passion for nursing